Trastuzumab BS Specific Use Results Survey
Not Applicable
- Conditions
- HER2 positive gastric cancer
- Registration Number
- JPRN-jRCT2071230094
- Lead Sponsor
- / / /
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
HER2 positive gastric cancer
Exclusion Criteria
Not set: The following is set as a precaution when selecting patients.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety: Adverse events<br>Efficacy: tumor reduction effect, best overall effect
- Secondary Outcome Measures
Name Time Method